US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is…
In Conversation
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…
Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent…
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion,…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment…
Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical…
France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like?…
The French President declared that he intended to make France the most welcoming and attractive place for the healthcare industry. Do you think this is possible?…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the…
